Replies to post #11099 on FutureLand Corp (FUTL)

[BlueAlien]

Maybe annuals with solar acquisition numbers included.

[BlueAlien]

Like the R&D PIPELINE with Apotheca

On September 15, 2017, the Company purchased 20% of Apotheca Biosciences, Inc. for an undisclosed amount. Apotheca Biosciences is developing cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry. Their pipeline of products includes, transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids.